Impact of Immunization Safety Monitoring on Vaccine Coverage

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 67

Special Issue Editor


E-Mail
Guest Editor
Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA
Interests: immunization safety

Special Issue Information

Dear Colleagues,

Despite progress in immunization recovery, immunization coverage remains lower than before the COVID-19 pandemic. Global immunization stakeholders have committed to achieving immunization recovery and reaching zero-dose communities. They are focusing their efforts on raising vaccination levels and protecting vulnerable and special populations from vaccine-preventable diseases. In addition to ensuring equitable access to immunizations, it is essential to consider immunization safety concerns, as they are a significant driver of vaccine hesitancy.

This Special Issue aims to highlight immunization safety in improving immunization coverage. We welcome original research articles and reviews focusing on research areas that include disparities in immunization coverage, immunization safety, active vaccine safety surveillance, adverse events following immunization, digital innovations for immunization program monitoring, barriers to reporting immunization safety events, advances to address immunization safety information and strategies to increase the demand for vaccines.

Dr. Jane F. Gidudu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine safety
  • immunization safety
  • adverse events following immunization
  • vaccination coverage
  • vaccine hesitancy
  • pharmacovigilance
  • information systems
  • active surveillance
  • mis- and dis-information

Published Papers

This special issue is now open for submission.
Back to TopTop